Perspective Therapeutics (CATX) Total Current Liabilities (2011 - 2026)

Perspective Therapeutics has disclosed Total Current Liabilities across 16 years of filings, most recently posting $31.5 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $31.5 million, up 148.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.5 million (up 148.33% YoY), and the FY2025 annual result was $28.7 million, up 57.32% from the prior year.
• Total Current Liabilities came in at $31.5 million for Q1 2026 at Perspective Therapeutics, up from $28.7 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $31.5 million in Q1 2026 to a low of $2.0 million in Q1 2022.
• The 5-year median for Total Current Liabilities is $12.7 million (2025), against an average of $13.5 million.
• Across the five-year window, Total Current Liabilities soared 402.37% in 2023 and fell 26.74% in 2025, its largest moves.
• Perspective Therapeutics' Total Current Liabilities stood at $3.1 million in 2022, then jumped by 402.37% to $15.7 million in 2023, then rose by 16.38% to $18.2 million in 2024, then surged by 57.32% to $28.7 million in 2025, then gained by 9.79% to $31.5 million in 2026.
• The last three Total Current Liabilities figures came in at $31.5 million (Q1 2026), $28.7 million (Q4 2025), and $20.6 million (Q3 2025), per Business Quant data.